Ignite Creation Date:
2025-12-24 @ 12:43 PM
Ignite Modification Date:
2026-01-04 @ 6:08 AM
Study NCT ID:
NCT03274661
Status:
COMPLETED
Last Update Posted:
2023-10-19
First Post:
2017-09-05
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Pembrolizumab Activity in Patients With Homologous Recombination Competent and Deficient Tumors
Sponsor:
Baptist Health South Florida
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-11-03
Start Date Type:
ACTUAL
Primary Completion Date:
2020-10-20
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-03-19
Completion Date Type:
ACTUAL
First Submit Date:
2017-09-05
First Submit QC Date:
None
Study First Post Date:
2017-09-07
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2023-08-22
Results First Submit QC Date:
None
Results First Post Date:
2023-10-19
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-09-26
Last Update Post Date:
2023-10-19
Last Update Post Date Type:
ACTUAL